Endothelial cell infection and endotheliitis in COVID-19 - The Lancet
Por um escritor misterioso
Descrição
Efficacy and safety of baricitinib or ravulizumab in adult
Is It All About Endothelial Dysfunction and Thrombosis Formation
Endothelial thrombomodulin downregulation caused by hypoxia
Endothelial activation and dysfunction in COVID-19: from basic
Endothelial cells are not productively infected by SARS‐CoV‐2
Oxidative stress-induced endothelial dysfunction and decreased
Frontiers The Enigma of Endothelium in COVID-19
Prevention and management of thrombosis in hospitalised patients
Imperfect storm: is interleukin-33 the Achilles heel of COVID-19
